Medical specialists from France tagged as investigators in clinical trials studying Growth Hormone Deficiency

Total 5 results

Lecompte Pierre, Professor
Seen in:
- Tours, UH of Tours
Trials:
- NCT00187993 (Principal Investigator)
Conditions:
- Growth Hormone Deficiency
Reznik Yves, Professor
Seen in:
- Caen, UH of Caen
Trials:
- NCT00187993 (Principal Investigator)
Conditions:
- Growth Hormone Deficiency
Rohmer Vincent, Professor
Seen in:
- Angers, UH of Angers
Trials:
- NCT00187993 (Principal Investigator)
Conditions:
- Growth Hormone Deficiency
Sonnet Emmanuel, Doctor
Seen in:
- Brest, UH of Brest
Trials:
- NCT00187993 (Principal Investigator)
Conditions:
- Growth Hormone Deficiency
Tessier Marie-Pierre, Professor
Seen in:
- Limoges, UH of Limoges
Trials:
- NCT00187993 (Principal Investigator)
Conditions:
- Growth Hormone Deficiency

Clinical Trials on Growth Hormone Deficiency

Novo Nordisk A/S

Completed

Effect of Somatropin on Left Ventricular Mass in Growth Hormone Deficient Adult Patients

Growth Hormone Disorder | Adult Growth Hormone Deficiency

France
Novo Nordisk A/S

Completed

Dose Study in Growth Hormone Deficient Adults Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC126-0083

Growth Hormone Disorder | Adult Growth Hormone Deficiency

Denmark
Novo Nordisk A/S

Completed

Safety and Efficacy of Long-term Somatropin Treatment in Adults (NordiWIN)

Growth Hormone Disorder | Adult Growth Hormone Deficiency

Germany
Novo Nordisk A/S

Completed

A Single Dose Trial in Growth Hormone Deficient Children Investigating Safety, Pharmacokinetics and Pharmacodynamics of Long Acting Growth Hormone

Growth Hormone Disorder | Growth Hormone Deficiency in Children

Israel, Denmark, Belgium, Spain, Macedonia, The Former Yugoslav Republic of, Turkey, United Kingdom, France, Slovenia, Czech Republic
Novo Nordisk A/S

Withdrawn

An Observational Study on Treatment Compliance by Children Treated With Growth Hormone (IMPACT)

Growth Hormone Disorder | Growth Hormone Deficiency in Children
Novo Nordisk A/S

Completed

A Single Dose Trial in Healthy Caucasians and Japanese Subjects Investigating the Pharmacokinetics of Somatropin

Healthy | Growth Hormone Disorder | Adult Growth Hormone Deficiency

United States
Teva Pharmaceutical Industries, Ltd.

Terminated

A Phase 2, Safety and Dose-Finding Study in Treatment-Naive, Pre-Pubertal, Growth Hormone-Deficient Children

Growth Hormone-Deficiency

Belarus, Bulgaria, Georgia, Greece, Hungary, Israel, Poland, Romania, Russian Federation, Serbia, Spain, Turkey, Ukraine
OPKO Health, Inc.

Completed

Safety and Efficacy Phase 2 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children

Pediatric Growth Hormone Deficiency

Greece, Hungary, Slovakia
Novo Nordisk A/S

Completed

Observational Study of Norditropin NordiFlex® With NordiFlex PenMate™

Growth Hormone Disorder | Growth Hormone Deficiency in Children | Delivery Systems

Germany, Netherlands, Sweden
OPKO Health, Inc.

Completed

MOD-4023 (Long-Lasting Human Growth Hormone (hGH)) Study in Growth Hormone Deficient Adults (GHDA)

Adult Growth Hormone Deficiency

Czechia, Hungary, Israel, Serbia, Slovakia, Slovenia

Medical specialists from France tagged as investigators in clinical trials studying Growth Hormone Deficiency

Clinical Trials on Growth Hormone Deficiency

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tanzania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations